Supplementary Data from Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer
Craig Furman,Xiaoling Puyang,Zhaojie Zhang,Zhenhua J. Wu,Deepti Banka,Kiran B. Aithal,Lee A. Albacker,Ming-Hong Hao,Sean Irwin,Amy Kim,Meagan Montesion,Alyssa D. Moriarty,Karthikeyan Murugesan,Tuong-Vi Nguyen,Victoria Rimkunas,Tarek Sahmoud,Michael J. Wick,Shihua Yao, Xun Zhang,Hao Zeng,Frédéric H. Vaillancourt,David M. Bolduc,Nicholas Larsen,Guo Zhu Zheng,Sudeep Prajapati,Ping Zhu,Manav Korpal crossref（2023）
摘要
Supplementary Data from Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer
更多查看译文
AI 理解论文
溯源树
样例
